藤村 昭夫 | 大分医科大学臨床薬理
スポンサーリンク
概要
関連著者
-
藤村 昭夫
大分医科大学臨床薬理
-
海老原 昭夫
大分医科大学医学部臨床薬理学
-
大橋 京一
自治医科大学臨床薬理
-
近藤 和興
自治医科大学臨床薬理
-
大橋 京一
自治医科大学臨床薬理学教室
-
中島 創
大分医科大学医学部臨床薬理学
-
熊谷 雄治
大分医科大学臨床薬理
-
都留 正展
大分医科大学臨床薬理
-
日野 尚子
大分医科大学臨床薬理
-
小手川 勤
大分医科大学臨床薬理
著作論文
- Pharmacokinetics, pharmacodynamics, and safety of bevantolol, a new .BETA.1-selective .BETA.-adrenoceptor antagonist, in Japanese healthy volunteers.
- Clinical pharmacological studies on a new .BETA.1 selective .BETA.-blocker, bevantolol.
- Clinical pharmacology of ibopamine. (1). Safety and pharmacological actions after single and multiple oral doses in Japanese healthy subjects.
- Clinical pharmacology of nitrendipine - Single- and multiple-dose study in Japanese healthy subjects.:Single- and Multiple-Dose Study in Japanese Healthy Subjects
- Influence of beta-adrenergic blocking agent on the circadian rhythm of blood pressure in patients with essential hypertension.
- Clinical phase I studies of a new antiemetic drug, SN-307 (ondansetron).
- Clinical pharmacology of a new antiplatelet drug, KBT-3022. Results of single administration in Japanese healthy adults.
- Clinical pharmacology of a new antiplatelet drug, KBT-3022. Studies on repeated administration in healthy adults.
- Effect of beta-blockers on circadian rhythm of blood pressure in patients with essential hypertension.
- Clinical pharmacology of ibopamine. (2). Pharmacokinetics after single and multiple oral administration in healthy Japanese subjects.